Coherus BioSciences, Inc.
N/A
USD
N/A
N/A
...
Chart
Financials
Description
CHRS Company Description
Coherus BioSciences Inc is a commercial-stage biopharmaceutical company building an immuno-oncology franchise funded with cash generated by its diversified portfolio of FDA-approved therapeutics. The company is focused on the research, development, and commercialization of its portfolio of FDA-approved oncology products, including LOQTORZI. The company markets UDENYCA, a biosimilar of Neulasta in the United States, and expects to launch the FDA-approved Humira biosimilar YUSIMRY in the United States in 2023. The company generates revenue from the United States.
CHRS Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view CHRS Smart Score
Score Breakdown
CHRS Company Description
Show More
Coherus BioSciences Inc is a commercial-stage biopharmaceutical company building an immuno-oncology franchise funded with cash generated by its diversified portfolio of FDA-approved therapeutics. The company is focused on the research, development, and commercialization of its portfolio of FDA-approved oncology products, including LOQTORZI. The company markets UDENYCA, a biosimilar of Neulasta in the United States, and expects to launch the FDA-approved Humira biosimilar YUSIMRY in the United States in 2023. The company generates revenue from the United States. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of CHRS by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CHRS's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on CHRS's company Twitter account
WallStreetBets
Number of mentions of CHRS in WallStreetBets Daily Discussion
CHRS News
Recent insights relating to CHRS
CNBC Recommendations
Recent picks made for CHRS stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in CHRS
Corporate Flights
Flights by private jets registered to CHRS
Our Analysis